Dr. Alan K. Jacobs, M.D., a neurology specialist, will speak at a program on Multiple Sclerosis held Wednesday, Nov. 17, at The Centre at Bluffton, 601 N. Main St. Registration is at 6:30 p.m. and the program begins at 7 p.m.

The first oral medications (Fingolimod) For MS has been approved by the FDA. With this brings many question for a person with MS if the risk worth it and what are the risk. Dr. Jacobs will give his opinion on this new drug and answer any other question one may have.

Persons wanting additional information may contact Tracy Steele at [email protected].